Dallas-based Spectral AI (Nasdaq: MDAI) has announced continued progress in the development of DeepView SnapShot M, a handheld diagnostic tool for use in battlefield burn assessment.
The device is based on the AI-driven DeepView System platform developed by the company, which is focused on medical diagnostics for faster and more accurate treatment decisions in wound care.
“Successful burn wound management is essential to patient survival, and this need is magnified in the battlefield setting,” CEO Peter M. Carlson said in a statement. “Developing technology that can support our nation’s armed forces is a matter of much personal and professional pride for all of us at Spectral AI, and we’re honored to be a part of a select group of companies pursuing that objective.”
“We’re continuing to advance the evolution of this proprietary AI-driven burn wound assessment technology and believe that its potential applications can extend beyond military use to serve our first responders and other healthcare providers,” he added.
Spectral AI—which was founded in 2009 as a research spinoff from UT Southwestern—noted that burn wounds account for a significant portion of combat-related injuries, often resulting from explosive device detonation, penetrating injuries, or other trauma. The company said the availability of burn wound assessment and treatment expertise is often lacking in a battlefield setting.
Designed for quick and accurate wound assessment on the battlefield
Spectral AI said that DeepView SnapShot M is designed to be an integral part of the battlefield triage process by providing a quick and accurate wound assessment, so that those with more severe burn injuries can be prioritized for evacuation.
The company said its research and development team has continued to refine the device and is developing features necessary for military use.
Among the refinements is the miniaturization of the device’s five cameras, which have retained their ability to capture the same depth of wavelength as the company’s cart-based DeepView System with no tradeoff in tolerance or accuracy. The company said image capture time remains less than one second and the device’s cameras were optimized to reduce unwanted light, a challenge that’s present when imaging patients in a field-based setting rather than a clinically controlled environment.
Spectral AI also announced that an abstract titled, “Advancing Combat Burn Assessment of DeepView’s Handheld Device for Military Field Use” has been accepted for a poster presentation at the upcoming 2024 Military Health System Research Symposium being held on Aug. 26-29.
The Department of Defense’s foremost scientific meeting, the MHSRS is a joint symposium that provides a collaborative environment for presenting new scientific knowledge resulting from military-unique research and development.
![](https://s24806.pcdn.co/wp-content/uploads/2023/09/Spectral-MDs-DeepView-device-Photo-Spectral-AI.jpeg)
Spectral MD’s DeepView device for ERs and trauma centers [Photo: Spectral AI]
Previous $149M contract for device designed for ERs and trauma centers
Last year, the company was awarded a new contract valued at up to $149 million by the Biomedical Advanced Research and Development Authority (BARDA).
BARDA is part of the U.S. Department of Health and Human Services’ Administration for Strategic Preparedness and Response.
The contract is for the advanced development of Spectral MD’s DeepView System, an AI-driven burn wound imaging device designed to be used at emergency departments, trauma centers, and burn centers. The tech is used for both routine burn care and as a medical countermeasure for use in burn mass casualty incidents (BMCI), the company said.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.